Learning Objectives:

1. Describe the mechanism and clinical impact of pharmacogenomic interactions with chemotherapy and supportive care medications
2.  Discuss recent developments in pharmacogenomics of oncology care
3.  Utilize clinical decision support to interpret pharmacogenomic results and integrate into the therapeutic selection process

Session date: 
08/11/2022 - 8:00am to 9:00am CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Dyson Wake, Pharm.D.